No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs2131786 |
chr2:53651911-53651912 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs549432602 |
chr2:53651935-53651936 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs116088053 |
chr2:53651949-53651950 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs554765319 |
chr2:53652018-53652019 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs574920019 |
chr2:53652030-53652031 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs542444042 |
chr2:53652061-53652062 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs370131702 |
chr2:53652064-53652065 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs78151337 |
chr2:53652091-53652092 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs115661235 |
chr2:53652132-53652133 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs10189167 |
chr2:53652133-53652134 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
11 |
rs114715317 |
chr2:53652174-53652175 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs62139950 |
chr2:53652221-53652222 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs77037271 |
chr2:53652231-53652232 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs542103610 |
chr2:53652298-53652299 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs80321439 |
chr2:53652352-53652353 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs149630374 |
chr2:53652356-53652357 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs144400317 |
chr2:53652358-53652359 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs550373061 |
chr2:53652376-53652377 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs1565797 |
chr2:53652383-53652384 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
20 |
rs181796734 |
chr2:53652398-53652399 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs552911691 |
chr2:53652412-53652413 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs78453101 |
chr2:53652449-53652450 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs1565798 |
chr2:53652475-53652476 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs373373453 |
chr2:53652594-53652595 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs189496381 |
chr2:53656213-53656214 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs78269660 |
chr2:53656222-53656223 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs6732693 |
chr2:53656304-53656305 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs192049081 |
chr2:53656387-53656388 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs17044657 |
chr2:53656420-53656421 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
30 |
rs17044658 |
chr2:53656450-53656451 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
31 |
rs185002118 |
chr2:53656501-53656502 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs545531874 |
chr2:53656502-53656503 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs72806783 |
chr2:53656508-53656509 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
34 |
rs577762488 |
chr2:53656544-53656545 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs556521372 |
chr2:53656557-53656558 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs1521943 |
chr2:53656604-53656605 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
37 |
rs560177652 |
chr2:53656607-53656608 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs529183497 |
chr2:53656615-53656616 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs548546376 |
chr2:53656622-53656623 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs369832811 |
chr2:53656645-53656646 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs112940896 |
chr2:53656671-53656672 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs576659292 |
chr2:53656672-53656673 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs10496023 |
chr2:53656677-53656678 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
44 |
rs377508617 |
chr2:53656682-53656683 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs565290218 |
chr2:53656711-53656712 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs571370542 |
chr2:53656733-53656734 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs534123884 |
chr2:53656754-53656755 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs548006871 |
chr2:53656792-53656793 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs567940502 |
chr2:53656793-53656794 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs115063692 |
chr2:53656803-53656804 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|